review

Novel perspectives for neurodegeneration prevention: effects of bioactive polyphenols

Neurodegenerative diseases are becoming a big challenge for modern society. Neurodegenerative disorders strongly impact on patient and their caregivers. Moreover, since the population is becoming older, these pathologies will deeply influence medical and socio-economic conditions in the next years. CLICK TO REVIEW

Novel perspectives for neurodegeneration prevention: effects of bioactive polyphenols Read More »

Unmet needs in Parkinson disease: Motor and non-motor

Characterizing the clinical phenotype of the entire non-motor profile of PD is challenging. Further research and understanding are needed for discovering biomarkers of certain NMS, such as dementia, fatigue, pain, sleep, and apathy. More work is needed to gather a robust evidence base for guiding treatment of troubling NMS, which exert a major impact on

Unmet needs in Parkinson disease: Motor and non-motor Read More »

The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?

This review will discuss the potential use of probiotics for Parkinson’s disease prevention or treatment or as adjuvant therapy, confirming that gut microbiota modulation influences different pro-survival pathways. Future investigations in Parkinson’s disease should consider the role of the gut-brain axis and additional comprehension of the underlying mechanisms is extremely necessary. CLICK TO REVIEW

The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease? Read More »

Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation

Oxidative stress is highlighted as an important factor in the genesis of PD, involving several enzymes and signaling molecules in the underlying mechanisms of the disease. This review presents updated data on the involvement of oxidative stress in the disease, as well as the use of antioxidant supplements in its therapy CLICK TO REVIEW

Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation Read More »

Faecal Transplantation, Pro- and Prebiotics in Parkinson’s Disease; Hope or Hype?

. Faecal microbiome transplantation (FMT) is an attractive technique, because the administration is relatively simpleand in general has a mild adverse effect pattern. Moreover, FMT consists of a broad mixture, which could be beneficial,because at this moment it is not known what type of changes in the microbiome are needed. However, except from a fewcases

Faecal Transplantation, Pro- and Prebiotics in Parkinson’s Disease; Hope or Hype? Read More »

Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease

Increasing evidence is supporting the hypothesis of -synuclein pathology spreading from the gut to the brainalthough the exact etiology of Parkinson’s disease (PD) is unknown. Furthermore, it has been proposed that inflammation,via the gastrointestinal tract, potentially through infections, may contribute to -synuclein pathogenesis, and thus to the riskof developing PD. CLICK TO REVIEW

Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease Read More »

Fecal transplants as a microbiome-based therapeutic

Impaired microbiome diversity and composition can develop into a potent etiological agent of disease and increase susceptibility to infection. Given this, interventions targeting the microbiome have developed rapidly, with healthy donor feces being a de facto source of beneficial communities employed to rebalance patients’ microbiomes. Recent evidence has demonstrated that bacterial and viral richness, short

Fecal transplants as a microbiome-based therapeutic Read More »